Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Brian Piekos files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Venrock Healthcare Capital Partners III, L.P. - $3.69M of KALV open-market activity in the last 12 months
- Benjamin L. Palleiko - $1.30M of KALV open-market activity in the last 12 months
- Christopher Yea - $1.23M of KALV open-market activity in the last 12 months
- Paul K. Audhya - $430K of KALV open-market activity in the last 12 months
- Nicole Sweeny - $241K of KALV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Brian Piekos?
Brian Piekos is a corporate insider, tracked as Chief Financial Officer of KalVista Pharmaceuticals, Inc. (KALV). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Brian Piekos submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Brian Piekos been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($165K) across all tracked filings.
Where can I see all of Brian Piekos's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Brian Piekos and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
